This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: The Hospital for Sick Children, University Health Network. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2018
Title: The Innovations of Mario Moscarello
Introduction
Mario Moscarello is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for peptidyl arginine deiminase (PAD) enzymes. His work is crucial for addressing diseases associated with hypercitrullination of proteins.
Latest Patents
Mario Moscarello holds 1 patent for his invention titled "Inhibitors of peptidyl arginine deiminase (PAD) enzymes and uses thereof." This patent relates to imidazolidinecliones and compositions that include these compounds. The invention focuses on their application in treating diseases, disorders, or conditions linked to the hypercitrullination of proteins by PAD enzymes. The patent includes compounds of Formula I, along with their compositions and uses.
Career Highlights
Throughout his career, Mario has worked with esteemed institutions such as The Hospital for Sick Children and the University Health Network. His experience in these organizations has allowed him to collaborate with leading professionals in the field of medical research.
Collaborations
One of his notable coworkers is Lakshmi Premakanth Kotra. Their collaboration has contributed to advancements in the understanding and treatment of conditions related to PAD enzymes.
Conclusion
Mario Moscarello's innovative work in the field of biochemistry highlights the importance of research in developing treatments for complex diseases. His contributions continue to impact the scientific community and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile